MRI Guided Focused Ultrasound
MR guided Focused Ultrasound Surgery is a non-invasive procedure which uses high doses of focused ultrasound waves (HIFU) to destroy various lesions like uterine fibroids, adenomyosis, prostate cancer, bone metastasis, facetalarthropathy, etc without affecting the surrounding tissues. The procedure is conducted in a magnetic resonance imaging (MRI) scanner which helps the physician "see" inside the body to pinpoint, guide, and continuously monitor the treatment.
It is an alternative to medical and surgical mediation in the management of symptomatic uterine fibroids.
Through the treatment, the physicians non-invasively target and destroy the tissues. They heat the outer member of the bone that contain the pain-causing nerves, and then finally destroy them using high frequency and high energy sound waves.
MRgFUS is so disruptive that it will very likely overturn the other dominant current “technologies” e.g. surgery. Clinical studies demonstrate that MRgFUS is a safe and effective treatment for symptomatic uterine fibroids. Several studies have shown that MRgFUS significantly improves clinical symptoms in 70% to 80% of women with uterine myomas. Studies have also demonstrated a correlation between the treated volume of the myomas, improvement in symptoms, and lesion shrinkage. The results demonstrate that successful and durable treatment of uterine fibroids with MRgFUS necessitates selecting those patients for whom higher non-perfused volumes can be attained using the MRgFUS system.
What happens during the procedure?
During the procedure you lie on the treatment table that fits into a standard MRI scanner. Depending on the lesion to be treated either sedation or anesthesia is administered.
First MRI images are taken of the lesion to be treated. Then, after detailed planning, high energy focused ultrasound waves heat a small spot in the lesion to a temperature of up to 85oC. During the pulse or sonication the doctor monitors the progress and reviews temperature-sensitive images. Since each sonication treats a very small volume, this process will be repeated until the required volume is treated, typically about 50 times.
Your clinical team will be in the next room with two-way communication using a microphone and a speaker. Patients under mild sedation like those being treated for fibroids and facetalarthropathy will feel a warm sensation in the treatment area. You will be given a safety stop button that allows you to immediately stop the sonication if the treatment becomes painful.
How do I find out more about the procedure?
Initial telephone conversation: to provide more details on what the procedure entails and answer any questions you may have on the procedure. Information about insurance coverage and/or clinical trials may also be discussed. The clinical coordinator can send you a patient guide and additional information about the procedure.
Preliminary screening: if ExAblate is an option you wish to consider, the clinical coordinator will set up a preliminary screening for you to determine if you are a potential candidate for ExAblate.
MRI screening: once you have been determined a potential candidate, you will be invited for an MRI exam. This is called the "Screening Exam" to determine if the lesion is amenable for treatment.
Scheduling treatment: If you are eligible for the treatment, your clinical coordinator will then arrange a time and date for you to be treated, as well as provide you with instructions on how to prepare for the procedure. The clinical coordinator will also discuss with you post-procedure follow-up and expectations.
MR-guided focused Ultrasound provides an important new non-invasive and effective treatment for uterine fibroids. MRgFUS can be offered to the majority of patients suffering from symptomatic uterine fibroids. They suggest that the use of broader inclusion criteria as well as the mitigation techniques makes it possible to offer MRgFUS to a much larger subset of patients than previously believed. Recovery from the treatment is almost immediate and symptom relief is generally noticed sooner than alternative therapies. This is a tremendous advantage over existing options, which place a large burden on patients. Additional applications e.g. drug deliveries are under investigation and hold the promise of transforming the surgical arena to benefit millions of patients.
Magnetic Resonance-guided focused Ultrasound Surgery (MRgFUS) is an alternative to medical and surgical interventions in the management of symptomatic uterine fibroids. It is an effective non-invasive treatment with minimal associated risks. MRgFUS can be offered to a majority of patients suffering from symptomatic uterine fibroids. It has been suggested that the use of broader inclusion criteria as well as the mitigation techniques makes it possible to offer MRgFUS to a much larger subset of patients than previously believed.
In contrast to other invasive treatments for uterine fibroids, the relatively non-invasive MRgFUS requires no general anaesthesia. The ExAblate is the first device to combine magnetic resonance imaging (MRI) with high-intensity focused ultrasound to destroy tumours non-invasively. In contrast to other options, the non-invasiveness of the MRgFUS technique is associated with minimal risks and complications, overnight hospitalization is done for observation. The patient is discharged next day in the morning and allows most patients to return to work and their normal activities in one to two days.
Benefits of MR guided FUS?
Effective alternative to surgery and hormonal treatment.
Completely non-invasive - no surgery and no blood loss.
Quick return to normal activities.
Preserves the uterus and cervix.
Significant improvement in your quality of life.
Decrease in menstrual bleeding from symptomatic fibroids.
Decrease in urinary dysfunction, pelvic pain and/or pressure.
insurance companies that provide cashless insurance for MRgFUS are:
1) ALANKIT HEALTH CARE TPA LTD
2) ANMOL MEDICARE LTD
3) BAJAJ ALLIANZ
4) BUPA INTERNATIONAL
6) DEDICATED HEALTH CARE SERVICES TPA (INDIA) PVT LTD
7) E-MEDITEK SOLUTIONS TPA SERVICES LTD
8) FAMILY HEALTH PLAN LIMITED
9) FUTURE GENREALI INDIA INSUARNCE COMPANY LTD.
10) HEALTH INDIA TPA SERVICES PVT LTD
11) HERITAGE HEALTH TPA PVT LTD
12) ICICI LOMBARD GENRAL INSURANCE
13) IFFCO-TOKIO GENERAL INSURANCE CO. LTD
14) ICICI PRUDENTIAL LIFE INSURANCE
15) MAX BUPA HEALTH INSURANCE
16) MD INDIA HEALTH CARE SERVICES TPA PVT LTD
17) MEDI ASSIST INDIA PVT LTD
18) MEDICARE TPA SERVICES PVT
19) MEDSAVE HEALTH CARE LTD.
20) PARAMOUNT HEALTH SERVICES PVT LTD
21) PARK MEDICLAIM TPA PVT LTD
22) RAKSHA TPA
23) SAFEWAY TPA SERVICES PVT LTD
24) STAR HEALTH & ALLIED INSURANCE CO. LTD
25) TTK HEALTH CARE TPA PVT LTD
26) UNITED HEALTH CARE (PAREKH)
27) VIPUL MED CORP TPA PVT LTD
28) HDFC ERGO GENERAL INSURANCE
29) APOLLO MUNICH HEALTH INSURANCE
30) RELIGARE INSURANCE.
31) RELIANCE R-CARE
BEST UTERINE FIBROID TREATMENT IN MUMBAI
Jaslok Hospital is one of the few centers in the world that is FDA approved for MRgFUS of uterine fibroids. We have treated more than 400 patients with excellent results. MRgFUS is advantageous as it is totally non-invasive, preserves fertility, gives significant symptomatic relief (decrease in bleeding, pain, etc), good size reduction, improves quality of life and does not disturb hormonal balance. Most of the treated patients were able to resume daily activities the next day.